Genetic Technologies
GENE
#11116
Rank
โ‚น0.34 B
Marketcap
โ‚น71.83
Share price
0.00%
Change (1 day)
-66.79%
Change (1 year)

Operating Margin for Genetic Technologies (GENE)

Operating Margin as of November 2026 (TTM): -156.78%

According to Genetic Technologies's latest financial reports and stock price the company's current Operating Margin is -156.78%. At the end of 2022 the company had an Operating Margin of -105.42%.

Operating Margin history for Genetic Technologies from 2004 to 2008

Operating Margin at the end of each year

Year Operating Margin Change
2022-105.42%-98.2%
2021-5,870.91%-90.5%
2020-61,830.19%144.83%
2019-25,253.91%774.73%
2018-2,887.06%78.13%
2017-1,620.78%57.99%
2016-1,025.84%134.26%
2015-437.90%97.22%
2014-222.04%-19.8%
2013-276.84%92.92%
2012-143.50%-3009.59%
20114.93%-105.14%
2010-95.88%12.2%
2009-85.46%146.14%
2008-34.72%232.78%
2007-10.43%-80.57%
2006-53.71%-29.66%
2005-76.35%-57.62%
2004-180.17%285.9%
2003-46.69%-31.15%
2002-67.82%10.93%
2001-61.14%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Thermo Fisher Scientific
TMO
16.48%-110.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
12.60%-108.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
17.22%-110.98%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
7.93%-105.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
48.01%-130.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-7.65%-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-47.91%-69.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-6,510.13% 4,052.40%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.